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REVIEW

Plasticity of differentiated cells in wound repair and tumorigenesis,
part I: stomach and pancreas

ABSTRACT
For the last century or so, the mature, differentiated cells throughout
the body have been regarded as largely inert with respect to their
regenerative potential, yet recent research shows that they can
become progenitor-like and re-enter the cell cycle. Indeed, we
recently proposed that mature cells can become regenerative via a
conserved set of molecular mechanisms (‘paligenosis’), suggesting
that a program for regeneration exists alongside programs for death
(apoptosis) and division (mitosis). In two Reviews describing how
emerging concepts of cellular plasticity are changing how the field
views regeneration and tumorigenesis, we present the commonalities
in the molecular and cellular features of plasticity at homeostasis and
in response to injury in multiple organs. Here, in part 1, we discuss
these advances in the stomach and pancreas. Understanding the
extent of cell plasticity and uncovering its underlying mechanisms
may help us refine important theories about the origin and
progression of cancer, such as the cancer stem cell model, as well
as the multi-hit model of tumorigenesis. Ultimately, we hope that the
new concepts and perspectives on inherent cellular programs for
regeneration and plasticity may open novel avenues for treating or
preventing cancers.
KEY WORDS: Dedifferentiation, Plasticity, Regeneration, Stem cells,
Tumorigenesis

Introduction

The series of sequential cell fate choices governing how normal,
adult differentiated cells arise from their precursors has been well
delineated over the last decades. The opposite process, in which
cells dedifferentiate to reacquire progenitor properties, though noted
by pathologists over a century ago (Adami, 1900) and demonstrated
by occasional, pioneering studies (Box 1), only reentered the
scientific mainstream a decade ago, when Yamanaka and others
demonstrated that multiple adult cell types can be induced to return
to pluripotency (see Box 2 for a glossary of terms) (Takahashi and
Yamanaka, 2006). Since then, research has expanded to also
examine the native capacity of mature cells in vivo to reverse their
differentiated state in nearly all tissues (Mills and Sansom, 2015;
Tata and Rajagopal, 2016). The plasticity of cells in a tissue
manifests in multiple ways: stem cells (SCs) can interconvert to
other SC populations, mature cells can dedifferentiate to recapitulate
the earlier stages of their ontogeny, and mature cells can
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transdifferentiate to mature cell types of different lineages
(Jopling et al., 2011).
Cellular plasticity may be key to regeneration upon large-scale
injury, yet a tissue’s capacity for plasticity may also carry an
inherent potential for adverse consequences, such as cancer. Here,
we discuss how plasticity may help refine a long-standing model for
how cancer begins. The well-established ‘multi-hit model’
postulates that tumors arise when long-lived SCs accrue mutations
necessary for tumorigenesis (Fearon and Vogelstein, 1990).
Recently, though, it has become clear that individual SCs in mice
may not be as long-lived as traditionally believed (Lopez-Garcia
et al., 2010; Snippert et al., 2010; Baker et al., 2014), raising the
question of how a single SC could accumulate multiple mutations
over the course of years (Mills and Sansom, 2015). Even if the SC
population remains stable over time, intestinal SCs are relatively
short-lived, as SCs divide frequently and stochastically (Box 2),
commonly jostling each other out of the niche in mice (LopezGarcia et al., 2010; Snippert et al., 2010) and in humans (Baker
et al., 2014). Although some intestinal SCs tend to be longer-lived
(Ritsma et al., 2014) and SCs with oncogenic mutations hold a
competitive advantage over wild-type SCs in the intestinal crypt
(Snippert et al., 2014), the question remains whether SCs are the
sole population that accumulates tumor-inducing mutations over the
lifetime of an organism. Moreover, in organs such as the pancreas
that lack a constitutive SC, other cell types must accumulate such
tumor-inducing mutations.
Increasing evidence shows that plasticity can be involved in the
origin of cancers in numerous epithelial tissues (Giroux and Rustgi,
2017) and even astrocytes (Box 2) (Friedmann-Morvinski and
Verma, 2014). This Review highlights the diversity of cell types that
may accrue the ‘multiple hits’ defined by Kinzler and Vogelstein
(Vogelstein and Kinzler, 1993) and initiate tumor formation. A
more complete understanding of the process of mutation
accumulation may further improve our understanding of how
every organ produces tumors with a multitude of phenotypes that
vary not only from person to person but even within a single person:
tumors initiated by SCs or by cells at various stages of
differentiation or dedifferentiation may contribute to this diversity
(Visvader, 2011; Song and Balmain, 2015).
Plasticity can allow post-mitotic cells to re-enter the cell cycle,
and we have proposed that cycles of proliferation and quiescence
(Box 2) can favor tumorigenesis because accumulated mutations
can become fixed in long-lived differentiated cell populations. We
have termed this the ‘cyclical hit’ model, in which cell lineages
cycle through phases of dedifferentiation and redifferentiation,
allowing for the accumulation and unmasking of mutations in longlived cells (Fig. 1) (Mills and Sansom, 2015; Saenz and Mills,
2018).
In part I of this Review, we survey the current state of plasticity
research in the stomach and pancreas, both of which experience the
recruitment of long-lived, mature secretory cells back into the cell
1

Disease Models & Mechanisms

Joseph Burclaff and Jason C. Mills*

Box 1. Cell plasticity: a historic perspective
Biologists observed cellular plasticity in various animal models long before
the advent of genetic approaches (Brockes and Kumar, 2002; Singh et al.,
2010). The earliest studies began with observations of natural regenerative
abilities in animals, with Thevenot, Du Verney and Perrault demonstrating
lizard tail regeneration in 1686 (described in manuscript form in Thevenot
et al., 1733) and Spallanzani – who also did pioneering stomach studies
(reviewed in Saenz and Mills, 2018) – reporting salamander limb
regeneration in 1768 (Spallanzani, 1768). This was followed by
experiments showing that amphibians of the order Urodela, including
newts and salamanders, can regenerate retinas and lenses (Wachs, 1920;
Stone and Chace, 1941) as well as jaws and the olfactory apparatus
(Vallette, 1929). Studies became increasingly focused on the mechanisms
driving this regeneration, with the idea that the mesoderm dedifferentiates
to mediate the repair appearing by the mid 1900s (Chalkley, 1954).
The mid-twentieth century saw the advent of plasticity research at the
cellular level, starting with nuclear transfer experiments in frog eggs.
Studies through the 1950s had shown that the nucleus from a blastula
cell could be successfully transplanted into an enucleated egg and
grown to a tadpole (Briggs and King, 1952) and that nuclei from other
early developmental states were also viable (Gurdon, 1960). In 1962,
John Gurdon demonstrated that nuclei from a fully differentiated
intestinal cell from feeding tadpoles was competent to form a full
tadpole when transplanted into an enucleated egg (Gurdon, 1962).
Experiments on natural regeneration eventually expanded to include
many organs and species, including the zebrafish heart (Poss et al.,
2002) and the skin, kidney and Schwann cells of mice (Cai et al., 2007).
Studies have also become increasingly mechanistic, culminating in the
discovery of distinct factors necessary and sufficient for the
reprogramming of differentiated cells to a pluripotent state (Takahashi
and Yamanaka, 2006).

cycle upon certain types of physiological injury. We discuss how
recent advances in our knowledge of these events and their
governing mechanisms address how mature cells might initiate or be
involved in tumorigenesis, challenging the idea that adult SCs are
the sole cell type responsible for both accumulating mutations and
spawning cancers (White and Lowry, 2015). We end part I by
exploring the similarities between the responses in the two organs
and postulate that they might be governed by conserved cellular
programs, which hold important implications for cancer initiation.
Our analysis will be continued in part II of this Review (Burclaff and
Mills, 2018), where we discuss recent studies highlighting plasticity
in the skin and the intestine, and explore overall similarities in
plasticity and tumorigenesis across all four organs. Although the
cell fate changes and reprogramming that occur during epithelial-tomesenchymal transition are also important examples of cell fate
changes with cancer implications (Varga and Greten, 2017), they
are outside the scope of our Review, which will be confined to cellautonomous processes within cells that begin as and remain
epithelial cells, even as they become neoplastic.
Stomach

The stomach body (corpus) is lined by an epithelium that is flat on the
luminal (see ‘Lumen’, Box 2) surface but invaginates into glands
descending towards the musculature. The gland and its surface
epithelial cells form the gastric unit, which contains mucus-secreting
surface pit foveolar cells at the surface, mucous neck cells interspersed
between acid-secreting parietal cells in the neck region (Bredemeyer
et al., 2009), and zymogenic (Box 2) chief cells at the base (Karam
and Leblond, 1993a,b,c,d) (Fig. 2A). Proliferation in the healthy
gastric epithelium is overwhelmingly confined to morphologically
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Box 2. Glossary
Astrocytes: glial cells of the central nervous system, characteristically
with a star-like morphology.
Cerulein: a hyperactive analog of the pancreatic secretion-inducing
hormone cholecystokinin (CCK), causes pancreatic injury upon
injection.
Dysplasia: the presence of abnormal cell types in a tissue that carry
clear risk for progression to cancer.
Endocrine: cells that secrete hormones into the circulation.
Exocrine: cells that secrete proteins away from the body (e.g. into the
lumen of the gastrointestinal tract).
Gastritis: inflammation of the stomach lining.
Granules: small compact particles of substances within (secretory)
vesicles in cells.
Haploinsufficiency: when a phenotype manifests due to loss of one
wild-type allele of a gene.
Helicobacter pylori: gram-negative bacterium that colonizes the
stomachs of over 50% of the world’s population (Amieva and Peek,
2016). In some people, H. pylori cause inflammation with loss of parietal
cells and metaplastic alteration of chief cells, eventually leading to gastric
cancer.
Intestinal metaplasia: a pattern of reaction to injury wherein the
differentiation pattern of small or large intestinal epithelium develops
within other organs.
Lineage tracing: experiments to determine all progeny from a specific
cell by using cell-specific promotor genes to express reporter genes only
within target cells and their progeny.
Lumen: the space that is lined by an epithelium (e.g. the cavity of the
stomach where food begins to be digested).
Metaplasia/metaplastic cells: the process wherein otherwise normal
cells appear in the wrong tissue setting.
Nucleotide tracing: administering nucleotides tagged with a trackable
marker to monitor cells which were actively synthesizing DNA at the time
of administration.
Pancreatitis: inflammation of the pancreas.
Pluripotency: term for an undifferentiated cell with the potential to
become any cell in the body.
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Quiescence: when a cell is not actively cycling (e.g. remains in the G0
stage of the cell cycle).
Ras genes: gene superfamily encoding for small GTPase proteins which
transmit signals when activated, often promoting genes involved in cell
growth and survival. HRas, KRas and NRas are commonly mutated in
human cancers (Downward, 2003).
Schwann cells: cells of the peripheral nervous system that produce
myelin sheaths around neuronal axons.
Stochastically: randomly determined.
Zymogenic: term for a cell producing zymogens, inactive substances
that are converted to digestive enzymes.
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A Healthy gastric unit
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B Metaplastic unit
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Fig. 1. Proposed models of mature cells acting as cancer cells of origin.
We propose that long-lived mature cells may accumulate and store mutations,
eventually acting as – or giving rise to cells that can act as – cells of origin for
cancers in diverse tissues. This mutational accumulation may occur in two
main ways: (A) mature cells (dark blue) may accumulate mutations (yellow
triangles) as they maintain their mature functioning cell fate over time. The
mutations themselves or stressors may trigger dedifferentiation (teal cell). If the
acquired mutations are sufficiently carcinogenic, they may then block the cell
in the dedifferentiated state, causing it to expand as a clone that can give
rise to cancer (red). (B) The ‘cyclical hit’ model describes mature cells that
dedifferentiate and redifferentiate multiple times in response to injury/
inflammation. Each time the cells are called back into the cell cycle, replicative
stress can promote mutation accumulation. Differentiated cells can store such
mutations indefinitely. Eventually, a mutation or combination of mutations is
sufficient to block the cell in one of its replicative phases and lead to clonal
expansion and potential tumorigenesis.

undifferentiated cells located above the neck cells at the isthmus of
the unit. Based on their ultrastructure and on nucleotide tracing
(Box 2) studies (Hattori and Fujita, 1976; Mills and Shivdasani,
2011), these isthmal cells have long been assumed to be multipotent
SCs that fuel the replacement of all mature cells in the gastric unit,
although the extant data do not rule out other self-renewal
mechanisms (Bjerknes and Cheng, 2002; Quante et al., 2010;
Willet and Mills, 2016; Wright, 2016).
Although several candidate SC markers have been identified in
cells that populate the gastric unit (Phesse and Sansom, 2017)
(Table 1), none of these have been shown to be enriched exclusively
in the isthmal cells. This means that a verified marker of gastric
epithelial SCs in the body of the stomach remains to be identified.
Gastric plasticity

Chief cells are large, long-lived and non-proliferating cells that
devote their energies to producing digestive enzymes. However,
surprisingly, chief cells in both mice and humans are plastic: they
can disassemble their complex secretory apparatus (Capoccia et al.,
2013; Lo et al., 2017) to re-enter the cell cycle and, in some cases,
potentially act as reserve SCs upon injury (Stange et al., 2013). In
humans, Helicobacter pylori (Box 2) infection can cause chronic
atrophic gastritis (Box 2). In this condition, parietal cells die
(atrophy) and increased proliferation is observed among the
remaining cells in the gastric unit. In mouse models, both
H. pylori and various drugs can be used to kill the parietal cells
and force the recruitment of other cells as additional reserve SCs
(Sigal et al., 2015; Petersen et al., 2017b). Drugs that mimic the
H. pylori-induced cellular changes include high doses of the
selective estrogen receptor modulator tamoxifen (Huh et al., 2012;
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Pit cell
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Metaplastic
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Mitotically
active

Stem cell/
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Neck cell

Chief cell
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Fig. 2. The gastric unit and its response to injury. (A) The healthy gastric
unit, with pit cells at the opening to the gastric (stomach) lumen (Box 2), stem
cells at the isthmus, parietal cells and neck cells in the middle of the unit, and
chief cells at the base. Not pictured: endocrine and tuft cells. Proliferation (red
nuclei) is confined to the isthmus, with new pit cells migrating upwards
and parietal and mucous neck cells migrating downwards. Neck cells transition
to chief cells at the zone between the neck and the base of the gastric unit.
Colored arrows mark the direction of cell changes. (B) A metaplastic gastric
unit after injury, such as by Helicobacter pylori infection or acute
pharmacological agents. Parietal cells quickly die and mature chief cells
become metaplastic cells co-expressing chief and neck cell markers.
Proliferation occurs from the isthmus through the base, with paligenotic
(capable of dedifferentiation) chief cells re-entering the cell cycle.

Saenz et al., 2016), the neutrophil elastase inhibitor DMP-777
(Goldenring et al., 2000; Nomura et al., 2005) and its ortholog L635
(Weis et al., 2013). In all cases, the observed changes include loss of
parietal cells, loss of mature chief cells and the emergence of
metaplastic cells (Box 2). In the stomach, the metaplastic cells that
emerge upon parietal cell death express large amounts of trefoil
factor 2 (TFF2; also known as spasmolytic polypeptide), so the cell
lineage shifts in chronic atrophic gastritis have been called
spasmolytic polypeptide expressing metaplasia (SPEM).
SPEM cells were originally thought to arise via proliferation from
the isthmal SCs undergoing an alternative differentiation path, and
some continue to believe that to be the case (Hayakawa et al., 2015,
2017; Kinoshita et al., 2018), yet lineage tracing (Box 2) studies
with multiple genetic drivers (Table 1) from the base and isthmus of
the gastric unit in mice, with corroboration in human tissues,
indicate that the majority of SPEM cells, at least in the acute setting,
3
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Table 1. Commonly used lineage tracing markers
Promoter
gene
Sox2
Lrig1
Runx1
Troy
(Tnfrsf19)
Lgr5
Mist1
(Bhlha15)
Elastase
Pdx1
P48/PTF1

Cell specificity

Protein type

Methods for visualizing

References

Unclear but includes cells with SC activity
Putative gastric isthmal SC marker, also
some parietal and pit cells
Putative gastric isthmal SC marker, also
chief cells
Gastric chief cells and some parietal cells

Transcription factor
Transmembrane
protein
Transcription factor

Lineage trace: GFP
Lineage trace: YFP/lacZ, IF

Arnold et al., 2011; Willet and Mills, 2016
Choi et al., 2017
Matsuo et al., 2017

Surface receptor

Lineage trace: CreER or EGFP,
IF
Lineage trace: CreER or EGFP

Gastric chief cells
Gastric chief and rare isthmus cells and
pancreatic acinar cells
Pancreatic acinar cells
Full pancreas in development, islet-specific
in normal adult pancreas, ADM
Full pancreas in development, acinarspecific in adults

Surface receptor
Transcription factor

Lineage trace: CreER or GFP
Lineage trace: CreER, IF

Enzyme
Transcription factor

Lineage trace: tTa/tetO-Cre
Lineage trace: Cre, IHC

Leushacke et al., 2017
Tuveson et al., 2006; Stange et al., 2013;
Hayakawa et al., 2015
Grippo et al., 2003; Guerra et al., 2007
Hingorani et al., 2003

Transcription factor

Lineage trace: Cre

Hingorani et al., 2003

Nam et al., 2012; Stange et al., 2013

ADM, acinar-to-ductal metaplasia; CreER, cyclization recombination estrogen receptor; GFP/YFP, green/yellow fluorescent protein; IF, immunofluorescence;
IHC, immunohistochemistry; Lgr5, leucine-rich repeat containing G-protein-coupled receptor 5; Lrig1, leucine-rich repeats and immunoglobulin-like domains 1;
Mist1, basic helix-loop-helix family member a15; Pdx1, pancreatic and duodenal homeobox 1; Runx1, runt-related transcription factor 1; SC, stem cell; Sox2,
SRY-box 2; Troy, TNF receptor superfamily member 19; tTa/tetO, transactivator/Tet operator.

cell cycle re-entry. The stages and checkpoints were preserved in
pancreatic regeneration, and additional experiments, as well as other
literature, indicated that kidney and liver regeneration follow the
same sequence. Thus, there is support for a conserved cellular
regenerative/dedifferentiation program that has been called
‘paligenosis’, suggesting that cells, in addition to programs for
cell death (apoptosis), also have programs to regain regenerative
ability (Messal et al., 2018).
Gastric tumorigenesis

Since Pelayo Correa’s early work mapping the histological stages of
gastric cancer progression (Correa, 1988), it has been known that
patients with metaplasia/chronic atrophic gastritis have an increased
risk for gastric cancer (Hattori, 1986; Kakinoki et al., 2009;
Goldenring et al., 2010) and that gastric cancer seems to arise in a
stepwise fashion. The stages of gastric tumorigenesis cannot be fully
studied in mice, as no mouse models of gastric cancer faithfully
replicate late-stage human disease (Petersen et al., 2017b). Humans
with extensive metaplasia and SPEM nearly invariably also get
intestinal metaplasia (Box 2), but intestinal metaplasia does not seem
to be a common feature of injury response in mice. In some mouse
models, however, SPEM can progress to proliferative lesions with
histological abnormalities resembling human dysplasia (Box 2)
(Nomura et al., 2004; Petersen et al., 2017b). The architecture of the
gastric unit is beneficial for studies characterizing the initial steps of
gastric tumorigenesis, as the spatial separation between the normal
isthmal and injury-induced basal proliferation zones allows for
inferences to be made about the cells of origin for metaplasia and
dysplasia (Radyk and Mills, 2017). Multiple recent studies have
shown how proliferative dysplasia can be induced solely by
expressing activated Kirsten rat sarcoma (KRAS; see ‘Ras genes’,
Box 2) using multiple promoters found in chief cells (Choi et al.,
2016; Leushacke et al., 2017; Matsuo et al., 2017). Such studies show
that chief cells can act as cells of origin for tumorigenesis. As there is
no known promoter with reliable specificity for the isthmal SC in the
stomach, similar direct evidence does not exist for the SC acting as
another potential gastric cancer cell of origin, although this is
certainly a possibility that awaits better genetic tools for study in
future work. The ability of the chief cells to act as cells of origin
for gastric cancer is consistent with the ‘cyclical hit’ model of
4
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likely arise from chief cells that reprogram to express TFF2 and reenter the cell cycle (Lennerz et al., 2010; Nam et al., 2010;
Goldenring et al., 2011; Capoccia et al., 2013; Leushacke et al.,
2017; Matsuo et al., 2017; Mills and Goldenring, 2017) (Fig. 2B).
Gene promoters that have been used to lineage-trace chief cell
reprogramming into progenitor cells include: tumor necrosis factor
receptor superfamily member 19 (Tnfrsf19; known as Troy), which
is mostly expressed in mature chief cells; basic helix-loop-helix
family member A15 (Bhlha15; known as Mist1), which is almost
exclusively expressed in chief cells; and leucine-rich repeat
containing G protein-coupled receptor 5 (Lgr5), which are
likewise almost exclusively expressed in chief cells (Table 1).
Recent work further supports the interpretation that mature chief
cells are the predominant source of acute SPEM cells, showing that
SPEM can arise even when any potential proliferative contribution
from the SC or progenitor cells is abrogated (Radyk et al., 2018).
Interestingly, SPEM cells recapitulate many aspects of immature
cells in the early developing stomach, where there are abundant
proliferating cells that co-express TFF2 and markers of chief cell
differentiation (Keeley and Samuelson, 2010). The SPEM cells are
not characteristic of the adult isthmal SCs, which lack granules
(Box 2) or other ultrastructural characteristics of any specific
differentiated cell lineage (Box 2) (Karam and Leblond, 1993a).
Although parietal cell loss is nearly always correlated with
SPEM, a recent study demonstrated that highly targeted parietal cell
apoptosis alone is insufficient to induce metaplasia (Burclaff et al.,
2017). The cause and mechanism of SPEM initiation remain
enigmatic, although several players have been implicated, such as
requirement for a signaling cascade including extracellular signalregulated kinase (ERK), cluster of differentiation 44 (CD44), and
signal transducer and activator of transcription 3 (STAT3) (Khurana
et al., 2013), macrophages, and interactions between interleukins
IL-33 and IL-13 (Petersen et al., 2014, 2017a). Our group’s recent
work also characterizes a sequential, stepwise process that chief
cells use to reprogram: (1) autodegradation, (2) induction of
metaplastic gene expression, e.g. SRY-box 9 (SOX9) and TFF2,
and (3) cell cycle re-entry (Willet et al., 2018). Each step has
checkpoints that cells must traverse to complete proper tissue
regeneration. For example, blocking lysosomal functioning stopped
cells from inducing SOX9/TFF2, and inhibiting mTORC1 stopped

REVIEW

tumorigenesis, whereby long-lived chief cells may accumulate and
store mutations in rounds of dedifferentiation and redifferentiation in
chronic inflammation or metaplasia, possibly leading to tumorigenesis
(Fig. 1) (Mills and Sansom, 2015; Saenz and Mills, 2018).
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A Healthy exocrine pancreas
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B Mechanism of metaplastic changes in ADM
Inflammation

TGFα
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GATA6
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Similar to SPEM, ADM also correlates with increased risk for
tumorigenesis. Indeed, in mouse cancer models and in human
tissue, ADM seems to be the precursor lesion for pancreatic
intraepithelial neoplasia (PanIN) (Hruban et al., 2005; Zhu et al.,

KRAS

RAC1

mROS

PI3K

PTEN

YAP1
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MEK 1/2
℗-ERK

PDX1
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Pancreatic plasticity

A rich literature has illustrated the inherent plasticity in both the adult
endocrine and exocrine pancreatic lineages (Puri et al., 2015). Here,
we focus on the acinar cells and acinar-to-ductal metaplasia (ADM),
which fundamentally parallels gastric SPEM. As with SPEM, it is
possible that sporadic or focal ADM arises spontaneously as a
consequence of periodic physiological inflammation cycles that all
tissues experience over the lifetime of an organism. ADM can also be
induced experimentally in mice through cerulein (Box 2) injection,
pancreatic duct ligation, pancreatectomy (Box 2) or genetic
manipulation (Chan and Leung, 2007). During ADM, acinar cells
switch to a proliferative state, adopting a more cuboidal morphology
with a duct-like configuration (Blaine et al., 2010; Mills and Sansom,
2015). This process of mature acinar cells reverting to a regenerative
duct-like state has been alternatively referred to as dedifferentiation,
transdifferentiation or reprogramming in the published literature on
ADM. For the sake of clarity and consistency, we will be referring to
the changes undergone by these acinar cells as paligenosis, as the
process appears highly conserved with the changes gastric chief cells
and mature cells in other tissues undergo to become regenerative
(Willet et al., 2018). Similarly to SPEM resembling the embryonic
stomach, the cuboidal-ductal structures of ADM are also observed in
multipotent progenitor cells in the embryonic pancreas (Jensen et al.,
2005). Mouse models indicate that ADM is a process used by the
pancreas to regenerate more acinar cells following large-scale injury
(Jensen et al., 2005; Strobel et al., 2007; Fendrich et al., 2008) and, in
certain cases, ADM cells may serve as SCs for other cell types (Zhou
et al., 2008; Pan et al., 2013). Lineage tracing (De La O et al., 2008;
Habbe et al., 2008; Morris et al., 2010a; Houbracken et al., 2011) and
in vitro studies (Pinho et al., 2011) demonstrate that ADM cells
largely arise via paligenosis of mature acinar cells. Thus, acinar cells
are clearly capable of plasticity; however, it is possible that not all
acinar cells have this property in equal measure, and there may be
subpopulations of acinar cells with various levels of plasticity
(Wollny et al., 2016).

HB-EGF

NR5A2

PTF1A

MIST1
SOX9

NICD
NFκB
STAT3

Dedifferentiation

Redifferentiation

E47

KRAS

Acinar to ductal
metaplasia

Quiescent

Mitotically active

Key
Acinar cell

Ductal cell

Fig. 3. The exocrine pancreas and the mechanistic steps involved in acinarto-ductal metaplasia. (A) The healthy exocrine pancreas, with acinar cells
arrayed at the end of tubes lined by ductal cells. (B) Pancreatic acinar cells are
normally mature and post-mitotic. Following injury with physical damage,
chemical agents or expression of activated Kirsten rat sarcoma (KRAS), acinar
cells dedifferentiate to an embryonic duct-like state and re-enter the cell cycle (red
nuclei). Many mechanisms underlying this paligenotic process have been
identified. Inflammation drives dedifferentiation, with transforming growth factor
alpha (TGFα) and heparin-binding EGF-like growth factor (HB-EGF) ligands
received by EGFR, which activates KRAS (Jhappan et al., 1990; Sandgren et al.,
1990; Ardito et al., 2012). KRAS can activate protein kinase D1 (PRKD1) directly
(Liou et al., 2015a), through Yes-associated protein 1 (YAP1) (Gao et al., 2013;
Gruber et al., 2016) or through mitochondrial reactive oxygen species (mROS)
(Liou et al., 2016). PRKD1 then activates the transcription factors pancreatic and
duodenal homeobox 1 (PDX1), Notch1 (NICD) (Liou et al., 2015a), signal
transducer and activator of transcription 3 (STAT3) (Miyatsuka et al., 2006) and
nuclear factor kappa-B (NFκB), which drive dedifferentiation (Liou et al., 2016).
KRAS also causes downregulation of MIST1 (Pin et al., 2001) and increases
SRY-box 9 (SOX9) in acinar cells (Prevot et al., 2012; Grimont et al., 2015).
KRAS can also signal through Rac family small GTPase 1 (RAC1) to activate
phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) (Heid et al., 2011; Baer
et al., 2014; Wu et al., 2014), which activates the mitogen-activated protein kinase
1 (MEK)/extracellular regulated MAP kinase (ERK) signaling cascade (Collins
et al., 2014). Myelocytomatosis oncogene (C-MYC) activity is increased in
dedifferentiating acinar cells, inhibiting plastid transcription factor 1a (PTF1A)
(Sanchez-Arevalo Lobo et al., 2017). Nuclear receptor subfamily 5 group A
member 2 (NR5A2) also needs to be shut off for dedifferentiation to occur (von
Figura et al., 2014). Once dedifferentiated, metaplastic cells can redifferentiate to
acinar cells after the injury regresses, unless the presence of mutant,
constitutively active KRAS or a similar mutation blocks redifferentiation (Collins
et al., 2012), leading to metaplasia. Orange, transcription factors; yellow, other
cellular proteins; red, extracellular signaling proteins; green, small molecules.
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The pancreas is composed of two key secretory cell populations in
distinct compartments. Hormone-secreting endocrine (Box 2) cells
are housed in specialized islets of Langerhans (Elayat et al., 1995),
whereas exocrine (Box 2) acinar cells are at the terminus of a
network of ducts that carry their digestive enzymes to the duodenum
(Fig. 3A). Zymogenic acinar cells in the adult pancreas parallel
gastric chief cells, sharing function (digestive enzyme production),
structure (a specialized secretory subcellular architecture) and gene
expression [transcription factors that mediate the secretory cell
architecture: X-box binding protein-1 (Xbp1) and Mist1] (Pin et al.,
2001; Lo et al., 2017). Unlike the stomach, the adult pancreas lacks
actively proliferating cells, necessitating mature cell plasticity
whenever repair or proliferation are needed.
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2007), a clear precursor to pancreatic ductal adenocarcinoma
(PDAC) (Ferreira et al., 2017). In humans, chronic pancreatitis
(Box 2) resulting from alcohol consumption, smoking, familial
conditions or spontaneous occurrence (Lowenfels et al., 1993; Malka
et al., 2002; Hyun and Lee, 2014) increases risk for ADM, PanIN and
PDAC (Guerra et al., 2007). Overactive mutant KRAS is present in the
vast majority of PDACs (Almoguera et al., 1988) and at the PanIN
stage (Klimstra and Longnecker, 1994). Genetically engineered
mouse models faithfully recapitulate human PDAC tumorigenesis,
with human-like ADM, PanIN and PDAC progression observed
when constitutively active mutant KrasG12D is expressed in the
pancreas (Hingorani et al., 2005). Interestingly, although
constitutively active mutant KrasG12D is sufficient to cause ADM
when expressed during development, both throughout the pancreas
(Aguirre et al., 2003; Hingorani et al., 2003) or specifically in acinar
cells (Grippo et al., 2003; Tuveson et al., 2006), a subsequent study
by Guerra and colleagues demonstrated that induced expression of
mutant KrasG12V in mature acinar cells is not sufficient to induce
paligenosis in acinar cells of adult mice. Rather, additional damage,
such as cerulein injection, is required for mature acinar cells to
progress to ADM and unmask the tumorigenic potential of the
constitutively active KRAS (Guerra et al., 2007). Although KrasG12D
expressed in adult acinar cells can eventually be sufficient to drive
acinar cell dedifferentiation to ADM and PanIN (Habbe et al., 2008),
that is probably because sporadic injury and reprogramming events
occur over the lifetime of an animal, inducing ADM, unmasking the
mutant KRAS and causing clonal expansion. Accordingly, the
process is still greatly accelerated by cerulein injections (Carrière
et al., 2009), additional oncogenic mutations (Morris et al., 2010b) or
even by destabilizing the mature acinar cell gene regulatory network
via pancreas transcription factor 1 subunit alpha (Ptf1a)
haploinsufficiency (Box 2) (Krah et al., 2015).
Although many studies demonstrate how KRAS activation can
progress unidirectionally from ADM to PDAC, Collins et al. further
explored this plasticity by conditionally expressing KrasG12D until
PanIN was induced and then stopping KrasG12D expression. Most
PanINs regressed within 2 weeks of mutant KRAS withdrawal, and
green fluorescent protein tracing showed that the resulting healthy
cells derived from the original acinar cells in which mutant KRAS
expression was induced (Collins et al., 2012). Together, the results
suggest that ADM, and even PanIN, are largely reversible, unless
activated KRAS blocks redifferentiation, although aberrant KRAS
activation itself is not sufficient to trigger the initial change,
consistent with studies identifying KRAS mutations in healthy
human pancreas (Lüttges et al., 1999). The data are consistent with
our ‘cyclical hit’ model, in which the long-lived acinar cells might
silently accrue mutations through cycles of dedifferentiation and
redifferentiation until one final mutation, such as in KRAS, eventually
inhibits their ability to redifferentiate from the ADM stage, locking
them in a proliferative state that could lead to subsequent clonal
expansion and progression to additional mutations and neoplasia
(Fig. 1) (Mills and Sansom, 2015; Saenz and Mills, 2018).
Studying reprogramming (paligenosis) with respect to
tumorigenesis in the pancreas carries some advantages over the
stomach. The absence of SCs in the adult pancreas facilitates this,
because increased proliferation during injury-induced regeneration
must come from mature cells, whereas, in stomach and intestines,
professional proliferating SC populations may also play a role in
repair. Thus, studies of acinar cells are rapidly identifying the
signaling pathways and genetic mechanisms governing the acinar cell
changes, many of which will likely be shared in mechanisms of
paligenosis across different organs (Means and Logsdon, 2016;

Storz, 2017) (Fig. 3B). For example, we know that inflammation is
key to ADM, with cyclooxigenase-2 (COX2)-mediated production of
prostaglandin E being a key feature (Guerra et al., 2007; Liou et al.,
2013). Inhibitors of macrophage activation and inflammation block
ADM (Guerra et al., 2011; Liou et al., 2013). En route to ADM,
acinar cells express intercellular adhesion molecule 1 (ICAM-1) to
recruit additional macrophages (Liou et al., 2015b) and engage in
aberrant epidermal growth factor receptor (EGFR) signaling (Jhappan
et al., 1990; Sandgren et al., 1990; Ardito et al., 2012). Active KRAS
also promotes ADM by suppressing Hippo kinases that would
otherwise hold the mitogenic Yes-associated protein 1 (YAP1) (Gao
et al., 2013; Gruber et al., 2016) transcription factor at bay. KRAS
also promotes mitochondrial stress, creating mitochondrial reactive
oxygen species that upregulate EGFR via polycystic kidney disease 1
(PKD1)/nuclear factor kappa-light-chain-enhancer of activated B
cells (NFκB) (Liou et al., 2016), promoting ADM in a feed-forward
loop.
Similar to gastric chief cells, mature acinar cells express MIST1 to
maintain their subcellular secretory architecture (Pin et al., 2001; Lo
et al., 2017). Mist1─/─ mice or mice with defective MIST1 exhibit
both abnormal acinar cell maturation and ADM response (Pin et al.,
2001; Zhu et al., 2004). Forced constitutive Mist1 expression blocks
ADM in spite of the presence of constitutively active Kras G12D (Shi
et al., 2013). Other transcription factors are keenly involved in acinar
cell plasticity (Fig. 3B); notably, SOX9 (Furuyama et al., 2011;
Prevot et al., 2012; Grimont et al., 2015), myelocytomatosis oncogene
(C-MYC) (Sanchez-Arevalo Lobo et al., 2017) and Kruppel like
factor 4 (KLF4) (Wei et al., 2016) promote ADM, whereas PTF1A
(Krah et al., 2015; Benitz et al., 2016; Hoang et al., 2016; Jiang et al.,
2016; Sanchez-Arevalo Lobo et al., 2017), nuclear receptor subfamily
5 group A member 2 (NR5A2) (Flandez et al., 2014; von Figura et al.,
2014) and BHLH protein E47 (Kim et al., 2015) drive the cells to
maintain a more acinar-like differentiated phenotype.
As mentioned above, the process whereby acinar cells convert to
ADM parallels the process of gastric chief cells becoming SPEM.
Thus, the paligenosis program for conversion of mature cells to
regenerative cells is generally similar with the same stepwise
sequence of autodegradation, SOX9/metaplastic gene expression
and cell cycle re-entry. Accordingly, inhibition of autophagy/
lysosomes or mTORC1 activity blocks the progression to ADM as it
blocks progression to SPEM in the stomach (Willet et al., 2018). We
expect that we are only at the beginning of understanding such
shared processes in the progression of mature cells to metaplastic
cell cycle re-entry in the pancreas, stomach and multiple other
organs. Of course, some aspects of the process will likely be specific
to acinar cells, such as the importance of the transcription factor
PTF1A, because it supports pancreas-specific genes that are key to
acinar cell function (Jiang et al., 2016). However, our current studies
and the literature indicate a large swath of commonality, including
the induction of SOX9 as a key feature of paligenosis. Indeed,
SOX9 modulation as cells re-enter the cell cycle seems ubiquitous
throughout the gastrointestinal (GI) tract (Van Landeghem et al.,
2012; Roche et al., 2015). RAS signaling in dedifferentiation may
be even more universal, as it plays a role not only in GI organs, but
also in regenerating Schwann cells (Box 2) (Harrisingh et al., 2004),
astrocytes and neurons (Friedmann-Morvinski et al., 2012).
Conclusion

In the search for the cell of origin for epithelial cancers, investigators
have long favored stem and progenitor cells as the likely culprits,
owing to their constitutive proliferative capacity and supposed
longevity (Fearon and Vogelstein, 1990; Vogelstein and Kinzler,
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Table 2. Common proteins associated with dedifferentiation (paligenosis) and tumorigenesis
Protein

Stomach

Pancreas

References

RAS family

Drives tumorigenesis

Hingorani et al., 2005; Choi et al., 2016

MAPK
SOX9
YAP
NF-κB

Required for SPEM
Increased in SPEM cells
Increased in gastric cancer
Increased in epithelium following
Hp infection
Lost in SPEM
Required for SPEM

Drives tumorigenesis by
blocking redifferentiation
Required for ADM
Increased in ADM cells
Required for ADM
Increased in ADM cells

Khurana et al., 2013; Collins et al., 2014
Prevot et al., 2012; Willet et al., 2018
Gruber et al., 2016; Yu et al., 2017
Liou et al., 2013; Sokolova and Naumann, 2017

Lost in ADM
Required for ADM

Shi et al., 2013; Lo et al., 2017
Willet et al., 2018

MIST1
mTORC1

ADM, acinar-to-ductal metaplasia; Hp, Helicobacter pylori; MAPK, mitogen-activated protein kinase; MIST1, BHLHa15; mTORC1, mammalian target of
rapamycin complex 1; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; RAS, rat sarcoma; SOX9, SRY-box 9; SPEM, spasmolytic
polypeptide-expressing metaplasia; YAP, Yes-associated protein.

Data from the stomach and pancreas support a model wherein
mutations are acquired and stored through cycles of differentiation
and dedifferentiation until a neoplastic mutation such as KRAS
activation inhibits a paligenotic cell’s ability to redifferentiate,
which we describe as the cyclical hit model (Fig. 1B). This model
might also help answer longstanding questions about tumor
development. So-called ‘oncofetal’ gene expression in adult
tumors has long puzzled oncologists (Uriel, 1979), with genes
that are normally expressed only in early development becoming reexpressed in many tumors (Ährlund-Richter and Hendrix, 2014).
Metaplastic gene re-expression is the second stage of paligenosis
(Willet et al., 2018), consistent with the expression of embryonic
genes being observed in ADM (Jensen et al., 2005), and the
metaplastic stomach establishes morphology and cell types similar
to the developing fetal gastric epithelium (Keeley and Samuelson,
2010; Osaki et al., 2010). It is thus likely that tumor cells (re)express
these embryonic genes because the genes were reintroduced via a
paligenosis event that occurred at some point in one of their cellular
ancestors.
Clearly, we are only at the beginning of understanding how cell
plasticity plays a role in tumorigenesis and how tumors can adapt to
chemotherapy and radiation therapy. We will explore more angles in
part II of this Review (Burclaff and Mills, 2018), but experimental
data indicates that there may be an explosion of new ideas and
potential therapeutic approaches as scientists begin to explore the
concepts of cell plasticity and dedifferentiation, and the underlying
conserved mechanisms and cellular processes, in more depth.
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Planque, L., Lulka, H., Couderc, B., Bousquet, C., Garmy-Susini, B. et al.
(2014). Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras
is completely dependent on wild-type PI 3-kinase p110alpha. Genes Dev. 28,
2621-2635.
Baker, A.-M., Cereser, B., Melton, S., Fletcher, A. G., Rodriguez-Justo, M.,
Tadrous, P. J., Humphries, A., Elia, G., McDonald, S. A., Wright, N. A. et al.
(2014). Quantification of crypt and stem cell evolution in the normal and neoplastic
human colon. Cell Rep. 8, 940-947.
Benitz, S., Regel, I., Reinhard, T., Popp, A., Schaffer, I., Raulefs, S., Kong, B.,
Esposito, I., Michalski, C. W. and Kleeff, J. (2016). Polycomb repressor
complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in
acinar-to-ductal metaplasia and pancreatic cancer cells. Oncotarget 7,
11424-11433.
Bjerknes, M. and Cheng, H. (2002). Multipotential stem cells in adult mouse gastric
epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G767-G777.
Blaine, S. A., Ray, K. C., Anunobi, R., Gannon, M. A., Washington, M. K. and
Means, A. L. (2010). Adult pancreatic acinar cells give rise to ducts but not endocrine
cells in response to growth factor signaling. Development 137, 2289-2296.
Bredemeyer, A. J., Geahlen, J. H., Weis, V. G., Huh, W. J., Zinselmeyer, B. H.,
Srivatsan, S., Miller, M. J., Shaw, A. S. and Mills, J. C. (2009). The gastric
epithelial progenitor cell niche and differentiation of the zymogenic (chief ) cell
lineage. Dev. Biol. 325, 211-224.
Briggs, R. and King, T. J. (1952). Transplantation of Living Nuclei From Blastula
Cells into Enucleated Frogs’ Eggs. Proc. Natl. Acad. Sci. USA 38, 455-463.
Brockes, J. P. and Kumar, A. (2002). Plasticity and reprogramming of differentiated
cells in amphibian regeneration. Nat. Rev. Mol. Cell Biol. 3, 566-574.
Burclaff, J. and Mills, J, C. (2018). Plasticity of differentiated cells in wound
repair and tumorigenesis, part II: skin and intestine. Dis. Model Mech. 11,
dmm035071. doi: 10.1242/dmm.035071
Burclaff, J., Osaki, L. H., Liu, D., Goldenring, J. R. and Mills, J. C. (2017).
Targeted apoptosis of parietal cells is insufficient to induce metaplasia in stomach.
Gastroenterology 152, 762-766.e7.
Cai, S., Fu, X. and Sheng, Z. (2007). Dedifferentiation: a new approach in stem cell
research. Bioscience 57, 655-662.
Capoccia, B. J., Jin, R. U., Kong, Y.-Y., Peek, R. M.Jr, Fassan, M., Rugge, M. and
Mills, J. C. (2013). The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal
secretory cell maturation. J. Clin. Invest. 123, 1475-1491.
Carrière, C., Young, A. L., Gunn, J. R., Longnecker, D. S. and Korc, M. (2009).
Acute pancreatitis markedly accelerates pancreatic cancer progression in mice
expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 382, 561-565.
Chalkley, D. T. (1954). A quantitative histological analysis of forelimb regeneration in
Triturus viridescens. J. Morphol. 94, 21-70.
Chan, Y. C. and Leung, P. S. (2007). Acute pancreatitis: animal models and recent
advances in basic research. Pancreas 34, 1-14.
Choi, E., Hendley, A. M., Bailey, J. M., Leach, S. D. and Goldenring, J. R. (2016).
Expression of activated ras in gastric chief cells of mice leads to the full spectrum
of metaplastic lineage transitions. Gastroenterology 150, 918-930.e913.
Choi, E., Lantz, T. L., Vlacich, G., Keeley, T. M., Samuelson, L. C., Coffey, R. J.,
Goldenring, J. R. and Powell, A. E. (2017). Lrig1+ gastric isthmal progenitor cells
restore normal gastric lineage cells during damage recovery in adult mouse
stomach. Gut doi: 10.1136/gutjnl-2017-313874.
Collins, M. A., Bednar, F., Zhang, Y., Brisset, J.-C., Galbá n, S., Galbá n, C. J.,
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